Due to higher mitochondrion-derived reactive oxygen species (ROS) in CD4+ than CD8+ T lymphocytes, the in vivo blockade of ROS reversed NAFLD-induced CD4+ T-lymphocyte depletion and retarded NAFLD-induced HCC (37). This evidence concerns the gene CD4 and hepatocellular carcinoma.